Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DexCom Inc (NASDAQ:DXCM)

70.23
Delayed Data
As of 4:00pm ET
 +0.77 / +1.11%
Today’s Change
57.68
Today|||52-Week Range
94.79
+17.64%
Year-to-Date
No recent news for DexCom Inc.

Today’s Trading

Previous close69.46
Today’s open69.06
Day’s range68.92 - 70.27
Volume870,140
Average volume (3 months)1,147,635
Market cap$6.0B
Dividend yield--
Data as of 4:00pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)-8.33%
Earnings growth (this year)+6.81%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+42.61%
P/E ratioNM
Price/Sales8.71
Price/Book20.71

Competitors

 Today’s
change
Today’s
% change
ABMDAbiomed Inc+0.32+0.20%
WSTWest Pharmaceutical ...+0.12+0.13%
MASIMasimo Corp+0.42+0.49%
IARTIntegra LifeSciences...-1.16-2.32%
Data as of 4:02pm ET, 09/20/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$573.3M
Annual profit (last year)-$65.6M
Net profit margin-11.44%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin Ronald Sayer
Senior Vice President-
Operations
Jeffrey C. Moy
Corporate headquarters
San Diego, California

Forecasts